Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $177,280 - $200,896
6,400 Added 0.82%
784,000 $22.7 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $9.98 Million - $11.7 Million
395,200 Added 103.35%
777,600 $21.8 Million
Q1 2024

Nov 05, 2024

SELL
$25.89 - $29.73 $10.2 Million - $11.7 Million
-395,200 Reduced 50.82%
382,400 $10.6 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $7.32 Million - $8.41 Million
282,900 Added 284.32%
382,400 $10.6 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $1.82 Million - $2.36 Million
69,500 Added 231.67%
99,500 $2.86 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $1.46 Million - $1.7 Million
-45,400 Reduced 60.21%
30,000 $995,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $2.35 Million - $2.72 Million
65,100 Added 632.04%
75,400 $2.77 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $6.29 Million - $8.19 Million
-159,800 Reduced 93.94%
10,300 $420,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $2.15 Million - $2.81 Million
-51,500 Reduced 23.24%
170,100 $8.72 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $2.25 Million - $2.75 Million
51,500 Added 30.28%
221,600 $9.7 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $6.14 Million - $7.61 Million
134,200 Added 373.82%
170,100 $8.81 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $4.55 Million - $6.74 Million
-110,100 Reduced 75.41%
35,900 $2.12 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $4.32 Million - $5.55 Million
110,100 Added 306.69%
146,000 $6.28 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $1.29 Million - $1.46 Million
35,900 New
35,900 $1.41 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.